Folate and Homocysteine Metabolism: Therapeutic Targets in Cardiovascular and Neurodegenerative Disorders

Author(s): Mark P. Mattson, Frank Haberman

Journal Name: Current Medicinal Chemistry

Volume 10 , Issue 19 , 2003

Become EABM
Become Reviewer


Individuals with elevated homocysteine levels are at increased risk for cardiovascular disease and stroke, and neurodegenerative disorders such as Alzheimers and Parkinsons diseases Homocysteine is a modified form of the amino acid methionine that is tightly regulated by enzymes requiring folate. By impairing DNA repair mechanisms and inducing oxidative stress, homocysteine can cause the dysfunction or death of cells in the cardiovascular and nervous systems. Dietary folate stimulates homocysteine removal and may thereby protect cells against disease processes. The enzymes involved in homocysteine and folate metabolism provide novel targets for drug discovery.

Keywords: apoptosis, atherosclerosis, dietary folic acid, schizophrenia, stem cells

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2003
Page: [1923 - 1929]
Pages: 7
DOI: 10.2174/0929867033456864
Price: $65

Article Metrics

PDF: 6